Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
B3516 DUBs-IN-3Summary: potent deubiquitinase enzyme inhibitor -
B3701 FPH1 (BRD-6125)1 CitationSummary: Hepatocyte functional proliferation enhancer -
B7535 Eeyarestatin ITarget: ERADSummary: inhibitor of endoplasmic reticulum-associated degradation (ERAD) and protein translocation -
B7637 SMER 28Summary: Positive regulator of autophagy -
B7727 NSC 624206Summary: Ubiquitin-activating enzyme (E1) inhibitor -
B7745 SZL P1-41Summary: Skp2 inhibitor -
B1317 ML-323Target: Deubiquitinating enzymes (DUBs)Summary: USP1-UAF1 inhibitor -
B1307 SJB3-019ATarget: USPSummary: Usp1 inhibitor -
B2151 STF-62247Target: AutophagySummary: Autophagy inducer in renal cell -
B1397 Trifluoperazine 2HClSummary: Dopamine D2 receptor inhibitor

